Intravitreal injection treats rare autoimmune disease of the central nervous system
Check out today's report!
A phase IIa proof of concept study of a novel rho-kinase (ROCK) inhibitor (AMA0076, Amakem NV) is now underway in patients with glaucoma and ocular hypertension.
Aflibercept (Eylea, Regeneron) has gained FDA approval for treatment of macular edema following CRVO and recommendation for approval by the CHMP for treatment of neovascular AMD.
QLT Inc. announces that it has completed sale of verteporfin for injection (Visudyne) to Valeant Pharmaceuticals International Inc.
A scientific research grant to cover studies related to dry eye and ocular surface disease will be awarded by CLAO ERF in association with the SSF.
AcuFocus Inc. has received approval from Health Canada to market and sell the Kamra inlay, an innovative corneal inlay to treat presbyopia, within Canada.
The iDesign aberrometer (Abbott) provides an advanced, high-definition measurement device for wavefront-guided LASIK procedures.
The AcrySof IQ ReSTOR +2.5-D IOL offers sharp distance vision with an additional range of vision beyond a standard monofocal lens.
Bausch &. Lomb has launched a new advertising campaign in six Florida markets aimed to educate baby boomers and seniors about its proprietary FDA-approved accommodating IOL (Crystalens), the company announced in a prepared statement.